SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Mar 19, 2024

2. SEC Identification Number

148022

3. BIR Tax Identification No.

000-288-655-000

4. Exact name of issuer as specified in its charter

Euro-Med Laboratories Phil., Inc.

5. Province, country or other jurisdiction of incorporation

Metro Manila

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

PPL Building, United Nations Avenue corner San Marcelino St., Manila Postal Code 1007

8. Issuer's telephone number, including area code

00-63-2-85240091 to 98

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares	4,112,140,540

11. Indicate the item numbers reported herein

Item 9 : Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Euro-Med Laboratories Phil., Inc.EURO

PSE Disclosure Form 7-1 - Notice of Annual or Special Stockholders' Meeting References: SRC Rule 17 (SEC Form 17-C) and
Sections 7 and 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Board Approval on Schedule of Annual Stockholders’ Meeting and Record Date
Background/Description of the Disclosure
Please be advised that our Board of Directors, at its regular meeting today, March 19, 2024 at 3:30p.m. in which a quorum was present and acted throughout, unanimously approved to hold the Annual Stockholders’ Meeting by remote communication via http://meeting.euromedlab.net on June 19, 2024 at 10:00am.

Type of Meeting

• Annual
• Special

Date of Approval by Board of Directors	Mar 19, 2024
Date of Stockholders' Meeting	Jun 19, 2024
Time	10:00AM
Venue	by remote communication via http://meeting.euromedlab.net
Record Date	May 20, 2024
Agenda	The Agenda of the meeting are as follows : 1.) Call to Order; 2.) Proof of Notice of Meeting; 3.) Certification of Quorum; 4.) Reading and Approval of the Minutes of the Previous Meeting; 5.) Management Report for the Fiscal Year 2023; 6.) Ratification of all Acts, Proceedings and Resolutions of the Board of Directors and Officers of the Corporation from the date of the last Annual Shareholders’ Meeting to the present; 7.) Approval of the Re-Nomination of Dr. William G. Padolina and Mr. Edwin D. Feist as Independent Directors 8.) Election of Directors for year 2024-2025; 9.) Appointment of External Auditor for year 2024-2025; 10.) Other Matters; and 11.) Adjournment.

Inclusive Dates of Closing of Stock Transfer Books

Start Date	May 14, 2024
End Date	May 17, 2024

Other Relevant Information
N/A